Delphi supports research and development teams building modular wearable and ingestible biosensors to continuously monitor internal biological signals, detect disease earlier, and guide treatment.
ARPA-H replaced Delphi’s solicitation section with selected awardees, removing the April 8, 2026 solution-summary and May 13, 2026 full-proposal deadlines and application links. The FAQ page is no longer available, and Leonard Tender replaces Paul E. Sheehan as program manager.
Funds research to develop, validate, and translate digital biomarkers (e.g., wearables, apps, sensors) for Alzheimer's disease detection and monitoring.
NIH Challenges seeks innovative smart devices and sensing technologies to generate AI-ready data and reduce chronic disease disparities in high-risk populations.
MIT-MGB Seed Program supports MIT and Mass General Brigham researchers and clinicians in joint research that develops or applies new technologies to transform clinical practice and address health problems.
Industry Discovery & Development Partnership Program supports companies developing therapeutics and devices through research and clinical trials to advance products that cure, treat, or prevent type 1 diabetes.
Funds innovative technology research from proof-of-concept to prototype, focusing on technological advances for biomedical research without testing biological or biomedical hypotheses.